Rf. Cohen et al., INTERLEUKIN-8 EXPRESSION BY HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Archives of otolaryngology, head & neck surgery, 121(2), 1995, pp. 202-209
Objective: To test the hypothesis that interleukin-8 (IL-8) is produce
d by human head and neck squamous cell carcinomas (HNSCCAs) and may th
erefore be a possible mediator for lymphocyte recruitment and neovascu
larization by these tumors. Methods: Nine fresh samples of HNSCCA were
analyzed for expression of IL-8 antigen using radioimmunoassay and im
munohistochemical staining techniques. Also, four short-term primary c
ultures of HNSCCA and two continuous HNSCCA cell lines were then analy
zed for production of IL-8 expression under both baseline conditions a
nd following stimulation with other cytokines. Results: The IL-8 antig
en was detected in all fresh tumor homogenates by radioimmunoassay (5.
58 to 331.69 ng of IL-8 per gram of tissue), and immunohistochemical r
esults localized staining predominantly within the tumor cells. Primar
y cultures of HNSCCA and continuous HNSCCA cell lines produced only lo
w levels of IL-8 (0.04 to 4.49 ng of IL-8 per 10(6) cells) under basel
ine (unstimulated) conditions. Stimulation of both primary cultures an
d cell lines with interleukin-1 and tumor necrosis factor induced sign
ificant increases in IL-8 antigen, while other cytokines failed to ind
uce a significant increase. Conclusions: This study demonstrates that
IL-8 antigen is expressed by HNSCCA in vivo, and that cultured HNSCCA
in vitro can be stimulated to express IL-8 antigen by both interIeukin
-1 and tumor necrosis factor. local production of IL-8 by HNSCCA cells
, and its regulation by other cytokines, may be important in both the
lymphocyte recruitment and tumor neovascularization seen in HNSCCA, an
d may thus ultimately affect the natural history of the disease.